Lung Cancer Management with Silibinin: A Historical and Translational Perspective.

Pharmaceuticals (Basel) · 2021 · PMC8230811 · PMID 34208282

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In such a small cohort, silibinin demonstrated highly significant clinical activity with a 75% overall response rate in the brain including three complete responses and ten partial responses [ 88 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.